Optimizing VA Community Care Biologics Prior Auth Workflows

The Landscape of VA Community Care for Biologics

The VA Community Care Network (VA CCN) facilitates veteran care outside VA facilities, managed by regional contractors like Optum (East) and TriWest (West). While designed to expand access, these arrangements introduce additional layers of administrative complexity for prior authorizations, particularly for high-cost specialty medications like biologics.

The Intricacies of Biologics Prior Authorization

Biologics, including TNF inhibitors, IL-17/23 inhibitors, IL-6 inhibitors, and JAK inhibitors, represent a significant portion of specialty drug prior authorizations due to their high cost and specific clinical criteria. Approvals often hinge on indication-specific guidelines, adherence to step therapy protocols, and documentation of essential screening requirements.

Core Biologics PA Requirements for VA Community Care Referrals

• Verification of indication-specific criteria for conditions across rheumatology, gastroenterology, and dermatology.
• Documentation of prior-line therapy history to satisfy step therapy requirements.
• Consideration of biosimilar substitution policies as mandated by payer guidelines.
• Evidence of necessary pre-treatment screenings, such as TB and hepatitis testing.
• Submission of clinical notes supporting continuous disease activity for periodic re-authorization cycles.
• Accurate routing based on medical versus pharmacy benefit, depending on administration.

Klivira's Strategic Automation for VA Community Care Biologics

Klivira integrates directly with EMRs to intelligently process prior authorizations for biologics, addressing the specific operational demands of VA Community Care referrals. Our platform streamlines the submission process, ensuring all required clinical data and documentation are accurately compiled and transmitted, regardless of the specific contractor (Optum or TriWest).

Klivira's Automated Biologics PA Workflow

• Indication Classification: Identifies specialty and disease state from EMR diagnoses for precise criteria matching.
• Step Therapy Automation: Automatically pulls prior-line therapy history to fulfill payer-specific step therapy rules.
• Biosimilar Substitution Routing: Applies payer-mandated biosimilar preferences, optimizing drug selection.
• Screening Documentation: Extracts and organizes required screening results (e.g., TB, hepatitis) from FHIR data.
• Periodic Re-authorization: Manages ongoing re-authorization cycles with automated tracking of disease activity and response.
• Benefit-Side Routing: Accurately routes submissions based on whether the biologic falls under medical or pharmacy benefit.

Enhancing Efficiency and Compliance for Veterans' Care

Automating VA Community Care biologics prior auth processes significantly reduces manual effort, accelerates turnaround times, and minimizes the potential for denials. This ensures that veterans receive their prescribed biologic therapies promptly, while healthcare organizations maintain compliance and optimize revenue cycle performance.